Dentists in Cheraw, SC Accepting Medicare
8 Dentists found. Showing 1 - 8
 Dr. Benjamin M Benzio, DMD Dentist Medicare: Medicare Enrolled Practice Location: 3137 Highway 9, Cheraw, SC 29520 Phone: 843-537-9044 |
Dr. Benjamin Craig Jordan, D.M.D. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1220 Chesterfield Hwy, Cheraw, SC 29520 Phone: 843-537-4368 Fax: 843-921-4612 |
Dr. William Michael Blackman, D.M.D. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1220 Chesterfield Hwy, Cheraw, SC 29520 Phone: 843-537-4368 Fax: 843-537-4368 |
Dr. Anthony Paul Blackman, D.M.D Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1220 Chesterfield Hwy, Cheraw, SC 29520 Phone: 843-537-4368 |
 Dr. Carrie Blackman Jordan, D.M.D. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1220 Chesterfield Hwy, Cheraw, SC 29520 Phone: 843-537-4368 Fax: 843-537-4368 |
Dr. Jonathan Mark Mitchell, D.M.D., PH.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 3137 Highway 9, Cheraw, SC 29520 Phone: 843-537-9044 |
Dr. Roachel William Laney, D.M.D Dentist Medicare: Not Enrolled in Medicare Practice Location: 3137 Hwy 9 W, Cheraw, SC 29520 Phone: 843-537-9044 Fax: 843-537-5853 |
Dr. Charles Randall Stafford, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 201 Cherry Dr, Cheraw, SC 29520 Phone: 843-537-2415 Fax: 843-537-7889 |
News Archive
Isis Pharmaceuticals reports final data from ISIS-APOCIIIRx Phase 2 study in patients with FCS
Isis Pharmaceuticals, Inc. announced the final data from its Phase 2 study of ISIS-APOCIIIRx as a monotherapy in patients with familial chylomicronemia syndrome, or FCS.
Political cartoon: 'Fear Itself'
Kaiser Health News provides a fresh take on health policy developments with "Fear Itself" by Steve Kelley.
FutureNeuro and Ergo partner to enhance eHealth infrastructure for providing better epilepsy care
FutureNeuro, the SFI Research Centre for chronic and rare neurological conditions based at RCSI, has announced its partnership with Irish Cloud solution provider Ergo to enhance crucial eHealth infrastructure in Ireland and provide improved monitoring for people living with epilepsy.
Valeant announces Alexza's receipt of FDA CRL for AZ-004 NDA
Valeant Pharmaceuticals International, Inc. announced today that Alexza Pharmaceuticals, Inc. has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding Alexza's New Drug Application (NDA) for AZ-004 (Staccato® loxapine) submitted as Adusuve™ Staccato® (loxapine) inhalation aerosol, 5 mg and 10 mg.
› Verified 4 days ago
Pharmacists
Dentists
Counselors
Clinical Social Workers
Occupational Therapists